Maximum quantity allowed is 999
请选择数量
CAS RN: 877399-00-3 | 產品號碼: B5682
(R)-5-Bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine
![(R)-5-Bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine Chemical Structure of (R)-5-Bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine](/medias/B5682.jpg?context=bWFzdGVyfHJvb3R8NTIwOTd8aW1hZ2UvanBlZ3xhREl4TDJobE55ODRPVEl3TXprNU1ESXdNRFl5TDBJMU5qZ3lMbXB3Wnd8OWUyMDBjOGNmMDIxNWY0YjdkMzFkMmJkYzJhZjMxNWY0MmVjY2ZjZDZhNjRjMjM1MTY0MGVkMGEyY2QyMDRkNA)
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | B5682 |
純度/分析方法 ![]() |
>98.0%(HPLC) |
分子式 / 分子量 | C__1__3H__1__0BrCl__2FN__2O = 380.04 |
外觀與形狀(20°C) | Solid |
儲存條件 ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器 ![]() |
1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 877399-00-3 |
Reaxys-RN | 12134679 |
PubChem Substance ID | 354335323 |
MDL編號 | MFCD18207061 |
產品規格
Appearance | White to Light yellow to Light orange powder to crystal |
Specific rotation(value) | -64.0 to -70.0 deg(C=1, CHCL3) |
Purity(HPLC) | min. 98.0 area% |
Purity(with Total Nitrogen) | min. 98.0 % |
Melting point | 108.0 to 113.0 °C |
性質
熔點 | 109 °C |
比旋光 [α]D | -67° (C=1,CHCl3) |
GHS
圖形表示 |
![]() |
信號詞 | Warning |
危險性說明 | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
防範說明 | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
相關法規
運輸資料
HS編碼* | 2933.39-000 |
Application
A Synthetic Intermediate of Tyrosine Kinase Inhibitors
This product has been used as a synthetic intermediate of tyrosine kinase inhibitors, such as crizotinib (PF-02341066).
References
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
- Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)
- Synthesis of a Crizotinib Intermediate via Highly Efficient Catalytic Hydrogenation in Continuous Flow
Application
A Key Synthetic Intermediate of Crizotinib
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
References
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
- Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)
考研文獻
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。